Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.47 |
| ▸ | FAAH | O00519 | 7/20 | 0.44 |
| ▸ | CASP2 | P42575 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 2/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | GLP1R | P43220 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2727698 | 0.99 | EPHX2 (0.48) | EPHX2FAAHCASP2CNR1CNR2 | |
| SCHEMBL3697473 | 0.97 | EPHX2 (0.47) | EPHX2FAAHCASP2CNR1CNR2 | |
| SCHEMBL837285 | 0.92 | GLP1R (0.48) | EPHX2FAAHCASP2CNR1CNR2 | |
| SCHEMBL837586 | 0.92 | GLP1R (0.48) | EPHX2FAAHCASP2CNR1CNR2 | |
| SCHEMBL27943740 | 0.89 | EPHX2 (0.44) | EPHX2FAAHCASP2LPAR1LPAR2 | |
| SCHEMBL3697476 | 0.89 | EPHX2 (0.44) | EPHX2FAAHCASP2LPAR1LPAR2 | |
| SCHEMBL28701810 | 0.89 | EPHX2 (0.44) | EPHX2FAAHCASP2LPAR1LPAR2 | |
| SCHEMBL2727705 | 0.89 | RECQL (0.46) | EPHX2FAAHCASP2CNR1CNR2 | |
| SCHEMBL2727567 | 0.88 | RECQL (0.45) | EPHX2FAAHCASP2CNR1CNR2 | |
| SCHEMBL29001684 | 0.88 | RECQL (0.45) | EPHX2FAAHCASP2CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4186969-B1 | SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION | HENKEL AG & CO KGAA (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20220168198-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2022-06-02 | — | — | US | disclosed |
| WO-2022111829-A1 | ESSENTIAL OILS OF CITRUS FRUITS FOR USE AS MEDICAMENT FOR INDUCED, INCREASED AND/OR ACCELERATED AUTOPHAGY IN HUMAN KERATINOCYTES | SYMRISE AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| EP-3993767-A1 | BLEND OF BEESWAX AND A LACTYLATE ESTER | Symrise AG (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3986365-A1 | SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES | Symrise AG (DE) | 2022-04-27 | — | — | EP | disclosed |
| US-20220117881-A1 | A HAIR CARE COMPOSITION | SYMRISE AG (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3982910-A1 | A COOLING PREPARATION | Symrise AG (DE) | 2022-04-20 | — | — | EP | disclosed |
| EP-2694834-B2 | KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS | BAUM MARC MICHAEL (US) | 2022-04-06 | — | — | EP | disclosed |
| WO-2022053140-A1 | SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES | SYMRISE AG (DE) | 2022-03-17 | — | — | WO | disclosed |
| US-20220071872-A1 | A LIQUID AND TRANSPARENT BLEND OF UV FILTERS | SYMRISE AG (DE) | 2022-03-10 | — | — | US | disclosed |
| US-20220047476-A1 | A METHOD FOR FIGHTING FEMALE BODY ODORS | SYMRISE AG (DE) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | KRT18, HCN4, COL14A1 | EPHX2 2997/4885FAAH 3621/4885CASP2 961/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | EPHX2 3916/4885FAAH 4153/4885CASP2 202/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | EPHX2 689/4885FAAH 660/4885CASP2 4305/4885 |
| US-20220047476-A1 | A METHOD FOR FIGHTING FEMALE BODY ODORS | SHBG, C5, CUTA | EPHX2 1552/4885FAAH 547/4885CASP2 818/4885 |
| US-20220168198-A1 | AN ANTIMICROBIAL MIXTURE | TMSB10, FHIT, EBP | EPHX2 2171/4885FAAH 2714/4885CASP2 1126/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | EPHX2 162/4885FAAH 464/4885CASP2 333/4885 |
| US-20220071872-A1 | A LIQUID AND TRANSPARENT BLEND OF UV FILTERS | F2, F12, TYR | EPHX2 4194/4885FAAH 166/4885CASP2 2922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.